China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

A recent study published in The Lancet Respiratory Medicine revealed an increase in lung cancer cases among non-smokers, ...

Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the rate of new cases continues to rise.

Researchers have published findings from the phase 2 LITESPARK-003 study of patients with previously untreated advanced clear ...